300406 九强生物
未开盘 09-19 09:30:00
资讯
新帖
简况
九强生物（300406）披露不向下修正“九强转债”转股价格，9月18日股价下跌1.09%
证券之星 · 09-18 15:00
九强生物（300406）披露不向下修正“九强转债”转股价格，9月18日股价下跌1.09%
九强生物(300406.SZ)：6项产品获欧盟IVDR CE认证
智通财经 · 09-17 08:19
九强生物(300406.SZ)：6项产品获欧盟IVDR CE认证
九强生物(300406.SZ)取得一项医疗器械注册证书
智通财经 · 09-16 08:06
九强生物(300406.SZ)取得一项医疗器械注册证书
股市必读：九强生物（300406）9月15日董秘有最新回复
证券之星 · 09-15
股市必读：九强生物（300406）9月15日董秘有最新回复
九强生物：取得五项发明专利证书 有利于提升公司核心竞争力
中国财富通 · 09-15
九强生物：取得五项发明专利证书 有利于提升公司核心竞争力
九强生物：化学发光产品线加快补充
证券之星 · 09-15
九强生物：化学发光产品线加快补充
九强生物（300406）披露关于九强转债预计触发转股价格向下修正条件的提示性公告，9月11日股价上涨1.08%
证券之星 · 09-11
九强生物（300406）披露关于九强转债预计触发转股价格向下修正条件的提示性公告，9月11日股价上涨1.08%
九强生物(300406.SZ)取得两项医疗器械注册证书
智通财经 · 09-09
九强生物(300406.SZ)取得两项医疗器械注册证书
九强生物最新公告：副董事长、总经理梁红军离任
证券之星 · 09-05
九强生物最新公告：副董事长、总经理梁红军离任
九强生物：肝素结合蛋白测定试剂盒取得医疗器械注册证书
格隆汇 · 09-03
九强生物：肝素结合蛋白测定试剂盒取得医疗器械注册证书
九强生物(300406.SZ)取得一项医疗器械注册证书
智通财经 · 09-02
九强生物(300406.SZ)取得一项医疗器械注册证书
九强生物（300406）2025年中报简析：净利润同比下降30.01%，公司应收账款体量较大
证券之星 · 08-27
九强生物（300406）2025年中报简析：净利润同比下降30.01%，公司应收账款体量较大
九强生物(300406)6月30日股东户数1.85万户，较上期增加21.57%
证券之星 · 08-27
九强生物(300406)6月30日股东户数1.85万户，较上期增加21.57%
九强生物(300406.SZ)发布上半年业绩，归母净利润1.75亿元，下降30.01%
智通财经 · 08-26
九强生物(300406.SZ)发布上半年业绩，归母净利润1.75亿元，下降30.01%
九强生物最新公告：取得狼疮抗凝物检测试剂盒医疗器械注册证
证券之星 · 08-22
九强生物最新公告：取得狼疮抗凝物检测试剂盒医疗器械注册证
九强生物最新公告：取得医疗器械注册证书
证券之星 · 08-12
九强生物最新公告：取得医疗器械注册证书
九强生物：受医保改革等多种因素影响
证券之星 · 07-28
九强生物：受医保改革等多种因素影响
6月23日增减持汇总：九强生物等2股增持 中国黄金等20股减持（表）
新浪证券 · 06-23
6月23日增减持汇总：九强生物等2股增持 中国黄金等20股减持（表）
九强生物(300406.SZ)股东中国医药投资公司拟斥不少于3000万元实施增持
智通财经 · 06-23
九强生物(300406.SZ)股东中国医药投资公司拟斥不少于3000万元实施增持
九强生物：公司作为国内体外诊断产业领军企业之一致力打造最优体外诊断检测平台
证券之星 · 06-18
九强生物：公司作为国内体外诊断产业领军企业之一致力打造最优体外诊断检测平台
加载更多
公司概况
公司名称：
北京九强生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2014-10-30
主营业务：
北京九强生物技术股份有限公司的主营业务是打造多元化、高质量体外诊断检测平台，目前拥有病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。2025年1月14日，公司荣获“军事科学技术进步一等奖”。
发行价格：
14.32
{"stockData":{"symbol":"300406","market":"SZ","secType":"STK","nameCN":"九强生物","latestPrice":13.67,"timestamp":1758243645000,"preClose":13.67,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":424000000,"shares":586000000,"eps":0.7803,"marketStatus":"未开盘","change":0,"latestTime":"09-19 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.7803,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758245400000},"marketStatusCode":0,"adr":0,"adjPreClose":13.67,"symbolType":"stock","openAndCloseTimeList":[[1758245400000,1758252600000],[1758258000000,1758265200000]],"highLimit":15.04,"lowLimit":12.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":586308628,"isCdr":false,"pbRate":2.05,"roa":"--","peRate":17.518903,"roe":"4.22%","epsLYR":0.92,"committee":0,"marketValue":8015000000,"turnoverRate":0,"status":2,"floatMarketCap":5802000000},"requestUrl":"/m/hq/s/300406","defaultTab":"news","newsList":[{"id":"2568406273","title":"九强生物（300406）披露不向下修正“九强转债”转股价格，9月18日股价下跌1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568406273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568406273?lang=zh_cn&edition=full","pubTime":"2025-09-18 23:00","pubTimestamp":1758207646,"startTime":"0","endTime":"0","summary":"九强生物近日发布公告称，截至2025年9月18日，公司股票价格已连续三十个交易日中至少有十五个交易日收盘价低于当期转股价格的85%，触发“九强转债”转股价格向下修正条款。公司于2025年9月18日召开第五届董事会第十八次会议，审议通过了《关于不向下修正“九强转债”转股价格的议案》。当前“九强转债”转股价格为16.68元/股，自2025年9月5日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800037920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","300406","BK0012","BK0077"],"gpt_icon":0},{"id":"2568466307","title":"九强生物(300406.SZ)：6项产品获欧盟IVDR CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2568466307","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568466307?lang=zh_cn&edition=full","pubTime":"2025-09-17 16:19","pubTimestamp":1758097144,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司6项产品于近日获得欧盟IVDR CE认证，包括：D-二聚体测定试剂盒(胶乳免疫比浊法)、钾测定试剂盒(丙酮酸激酶法)、钠测定试剂盒(半乳糖苷酶法)、总胆汁酸测定试剂盒(循环酶法)、高密度脂蛋白胆固醇测定试剂盒(直接法—过氧化物酶清除法)、低密度脂蛋白胆固醇测定试剂盒(直接法—表面活性剂清除法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FSXEmain","BK0239","BK4109","BK0077","BK4585","BK4588","BK0028","CE","BK0012","300406","BK0046","FESXmain"],"gpt_icon":0},{"id":"2567177923","title":"九强生物(300406.SZ)取得一项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567177923","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567177923?lang=zh_cn&edition=full","pubTime":"2025-09-16 16:06","pubTimestamp":1758009974,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，相关产品名称为：胃泌素17测定试剂盒(磁微粒化学发光免疫分析法)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1583","BK1222","300406","BK0046","BK0012","09996","BK0028","BK1100","159883","09997","BK0077","BK1574"],"gpt_icon":0},{"id":"2567144456","title":"股市必读：九强生物（300406）9月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2567144456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567144456?lang=zh_cn&edition=full","pubTime":"2025-09-16 03:15","pubTimestamp":1757963717,"startTime":"0","endTime":"0","summary":"截至2025年9月15日收盘，九强生物报收于13.79元，下跌1.01%，换手率0.83%，成交量3.52万手，成交额4860.63万元。目前公司已推出围绕全自动化学发光免疫分析仪Gi1600、Gi2000、Gi6000、Gi9000的相关化学发光产品，并将持续完善试剂菜单。后续将继续拓展新项目，并加大市场推广力度，将其作为新的增长点进行培育。当日关注点来自交易信息汇总：9月15日主力资金净流出197.61万元，显示主力小幅减持动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600003099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","300406","BK0012","BK0077"],"gpt_icon":0},{"id":"2567641112","title":"九强生物：取得五项发明专利证书 有利于提升公司核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2567641112","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567641112?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:01","pubTimestamp":1757941262,"startTime":"0","endTime":"0","summary":"9月15日，九强生物（300406）公告称，公司近日收到国家知识产权局颁发的5项《发明专利证书》。专利名称分别为“6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途”“万古霉素检测试剂盒”“偶联物的制备方法”“偶联物在制备苯妥英检测试剂中的用途”和“庆大霉素检测试剂盒”。上述发明专利证书的取得不会对公司近期生产经营产生重大影响，但有利于发挥公司的知识产权优势，促进技术创新，提升公司的核心竞争力，并形成持续创新机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=ra5Y4yzBPzs%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","300406","BK0028","BK0012","BK0239","BK0077"],"gpt_icon":0},{"id":"2567157114","title":"九强生物：化学发光产品线加快补充","url":"https://stock-news.laohu8.com/highlight/detail?id=2567157114","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567157114?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:51","pubTimestamp":1757940697,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物09月15日在投资者关系平台上答复投资者关心的问题。化学发光业务拓展：针对免疫赛道化学发光增速较快的情况，我们会加快补充化学发光产品线。目前公司已推出围绕全自动化学发光免疫分析仪Gi1600、Gi2000、Gi6000、Gi9000的相关化学发光产品，并将持续完善试剂菜单。同时，公司持续提高产品性能，提升检测的灵敏度、准确性和检测速度，以满足不同客户的需求，增强在化学发光市场的竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500030782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300406","BK0028","BK0012","BK0239","BK0077"],"gpt_icon":0},{"id":"2566992869","title":"九强生物（300406）披露关于九强转债预计触发转股价格向下修正条件的提示性公告，9月11日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566992869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566992869?lang=zh_cn&edition=full","pubTime":"2025-09-11 22:43","pubTimestamp":1757601797,"startTime":"0","endTime":"0","summary":"截至2025年9月11日收盘，九强生物报收于14.01元，较前一交易日上涨1.08%，最新总市值为82.14亿元。该股当日开盘13.87元，最高14.02元，最低13.63元，成交额达6570.63万元，换手率为1.12%。近日，公司发布关于九强转债预计触发转股价格向下修正条件的提示性公告。九强转债当前转股价格为16.68元/股，2025年7月23日至9月4日为16.98元/股。根据相关规定，若触发条件，公司董事会将审议是否修正转股价格，并及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100039133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0239","BK0012","BK0077","BK0046","BK0028"],"gpt_icon":0},{"id":"2566166261","title":"九强生物(300406.SZ)取得两项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2566166261","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566166261?lang=zh_cn&edition=full","pubTime":"2025-09-09 15:59","pubTimestamp":1757404774,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称：全自动凝血分析仪(型号MDC7600)、全自动化学发光免疫分析仪(型号Gi6000)。上述产品医疗器械注册证的取得，丰富了公司产品类别，有利于增强公司的核心竞争力，对公司未来发展具有正面影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300406","09996","BK1583","BK1222","BK0028","BK0046","09997","BK0077","BK1100","159883","BK0012","BK1574","BK0239"],"gpt_icon":0},{"id":"2565556084","title":"九强生物最新公告：副董事长、总经理梁红军离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2565556084","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565556084?lang=zh_cn&edition=full","pubTime":"2025-09-05 17:31","pubTimestamp":1757064678,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，梁红军因工作调动原因辞去公司副董事长、董事、董事会专门委员会及总经理职务。辞去上述职务后，梁红军不再担任公司任何职务。为保证公司相关工作顺利开展，总经理空缺期间，由董事长邹左军代行总经理职责，直至公司按程序聘任新任总经理为止。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500029147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0239","BK0012","300406","BK0077"],"gpt_icon":0},{"id":"2564336358","title":"九强生物：肝素结合蛋白测定试剂盒取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564336358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564336358?lang=zh_cn&edition=full","pubTime":"2025-09-03 15:55","pubTimestamp":1756886147,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","BK0028","BK1100","09997","BK0077","300406","BK1583","BK0239","BK1222","BK0012","159883","09996","BK0046"],"gpt_icon":0},{"id":"2564877552","title":"九强生物(300406.SZ)取得一项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564877552","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564877552?lang=zh_cn&edition=full","pubTime":"2025-09-02 16:46","pubTimestamp":1756802797,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称：胃泌素17测定试剂盒(胶乳免疫比浊法)。该试剂盒用于体外定量测定人血清中胃泌素17(G-17)的含量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK1100","BK0046","09996","300406","BK1583","09997","BK0028","BK1574","BK0239","BK0012","159883","BK1222"],"gpt_icon":0},{"id":"2562765337","title":"九强生物（300406）2025年中报简析：净利润同比下降30.01%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2562765337","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562765337?lang=zh_cn&edition=full","pubTime":"2025-08-28 06:28","pubTimestamp":1756333701,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期九强生物发布2025年中报。截至本报告期末，公司营业总收入6.68亿元，同比下降18.67%，归母净利润1.75亿元，同比下降30.01%。按单季度数据看，第二季度营业总收入3.49亿元，同比下降18.54%，第二季度归母净利润9197.63万元，同比下降29.1%。本报告期九强生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达197.93%。然而去年的净利率为32.02%，算上全部成本后，公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800006437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406"],"gpt_icon":0},{"id":"2562771148","title":"九强生物(300406)6月30日股东户数1.85万户，较上期增加21.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562771148","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562771148?lang=zh_cn&edition=full","pubTime":"2025-08-27 17:36","pubTimestamp":1756287412,"startTime":"0","endTime":"0","summary":"证券之星消息，近日九强生物披露，截至2025年6月30日公司股东户数为1.85万户，较3月31日增加3286.0户，增幅为21.57%。户均持股数量由上期的3.86万股减少至3.18万股，户均持股市值为44.96万元。在医疗器械行业个股中，九强生物股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.23万户。根据统计，九强生物2025年3月31日至2025年6月30日，主力资金净流出7849.63万元，游资资金净流入1.73亿元，散户资金净流出9487.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700037360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","300406","BK0046","BK0239","BK0028"],"gpt_icon":0},{"id":"2562411738","title":"九强生物(300406.SZ)发布上半年业绩，归母净利润1.75亿元，下降30.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562411738","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562411738?lang=zh_cn&edition=full","pubTime":"2025-08-26 19:21","pubTimestamp":1756207266,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布2025年半年度报告，该公司营业收入为6.68亿元，同比减少18.67%。归属于上市公司股东的净利润为1.75亿元，同比减少30.01%。归属于上市公司股东的扣除非经常性损益的净利润为1.73亿元，同比减少30.08%。基本每股收益为0.3元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"九强生物(300406.SZ)发布上半年业绩，归母净利润1.75亿元，下降30.01%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300406"],"gpt_icon":0},{"id":"2561422280","title":"九强生物最新公告：取得狼疮抗凝物检测试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2561422280","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561422280?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:02","pubTimestamp":1755853376,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为狼疮抗凝物检测试剂盒（凝固法），注册证编号为京械注准20252400780，注册类别为Ⅱ类，有效期至2030年8月17日。该试剂盒用于体外定性检测人血浆中的狼疮抗凝物（LA）。此注册证的取得丰富了公司产品类别，增强核心竞争力，对未来发展有正面影响，但对近期生产经营和业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200030515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0012","BK1222","159883","BK0239","BK1100","BK1574","09997","BK1583","BK0046","09996","BK0077","BK0028"],"gpt_icon":0},{"id":"2558610063","title":"九强生物最新公告：取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2558610063","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558610063?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:54","pubTimestamp":1754988878,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为免疫球蛋白A测定试剂盒（胶乳免疫比浊法），注册证编号为京械注准20252400761，注册类别为Ⅱ类，有效期至2030年8月6日。该试剂盒用于体外定量测定人尿液、脑脊液中免疫球蛋白A（IgA）的含量。该产品丰富了公司产品类别，有利于增强公司核心竞争力，但对近期生产经营和业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081200028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","09996","BK0012","BK1100","BK0028","BK0046","159883","BK1574","BK1583","BK0077","BK1222","300406","BK0239"],"gpt_icon":0},{"id":"2554251097","title":"九强生物：受医保改革等多种因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2554251097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554251097?lang=zh_cn&edition=full","pubTime":"2025-07-28 15:03","pubTimestamp":1753686194,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物(300406)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司的应收账款为什么连续多年居高不下九强生物回复：您好，感谢您的关注。受医保改革等多种因素影响，医院回款速度下降，终端医院与经销商的结算周期延长，进而导致经销商结算周期延长。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800013849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0012","BK0239","BK0046","300406"],"gpt_icon":0},{"id":"2545630448","title":"6月23日增减持汇总：九强生物等2股增持 中国黄金等20股减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2545630448","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545630448?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:22","pubTimestamp":1750688520,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，6月23日，盘后信息发展、九强生物披露增持情况。包括振邦智能、运机集团、英诺激光、蕾奥规划、数字政通、艾可蓝、利扬芯片、博瑞医药（维权）、茂硕电源、石头科技、望变电气、中晶科技、云天励飞、五矿新能、中国黄金、开普云、瀚川智能、安恒信息、博闻科技、上海洗霸在内的20家A股上市公司披露减持情况。\n\n\n\n新浪合作大平台期货开户 安全快捷有保障\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-23/doc-infcataw0259974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","600916","300406","BK0209","BK0046","BK0028","BK0077","BK0239"],"gpt_icon":0},{"id":"2545041557","title":"九强生物(300406.SZ)股东中国医药投资公司拟斥不少于3000万元实施增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2545041557","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545041557?lang=zh_cn&edition=full","pubTime":"2025-06-23 18:58","pubTimestamp":1750676335,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司股东中国医药投资有限公司计划自2025年6月23日至2025年12月22日，通过集中竞价交易、大宗交易等法律法规允许的方式增持公司股票，计划增持公司股份金额不少于3000万元(含2025年6月23日已增持部分)，增持所需资金为自有资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九强生物(300406.SZ)股东中国医药投资公司拟斥不少于3000万元实施增持","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300406","BK0250","BK0012","BK0239","BK0010","BK0175","BK0188","BK0046","BK0077","BK0185","BK0082","600056","BK0028"],"gpt_icon":0},{"id":"2544692812","title":"九强生物：公司作为国内体外诊断产业领军企业之一致力打造最优体外诊断检测平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2544692812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544692812?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:06","pubTimestamp":1750230382,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物(300406)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，当前国际形势紧张，请问公司在核生化方面有没有相关检测或诊断产品，如无，是否有此方面的研究或开发？谢谢！九强生物回复：您好，公司作为国内体外诊断产业领军企业之一，致力打造最优体外诊断检测平台，目前拥有病理检测系统、生化检测系统、血凝检测系统、发光检测系统、血型检测系统、POCT检测系统和液体活检CTC，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800017581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","BK0012","300406","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758243703751,"stockEarnings":[{"period":"1week","weight":-0.0243},{"period":"1month","weight":-0.074},{"period":"3month","weight":0.0374},{"period":"6month","weight":-0.104},{"period":"1year","weight":0.2563},{"period":"ytd","weight":0.0757}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.028},{"period":"3month","weight":0.1404},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.4101},{"period":"ytd","weight":0.1432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京九强生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18517人(较上一季度增加21.57%)","perCapita":"22920股","listingDate":"2014-10-30","address":"北京市海淀区花园东路15号旷怡大厦5层","registeredCapital":"58630万元","survey":" 北京九强生物技术股份有限公司的主营业务是打造多元化、高质量体外诊断检测平台，目前拥有病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。2025年1月14日，公司荣获“军事科学技术进步一等奖”。","listedPrice":14.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九强生物,300406,九强生物股票,九强生物股票老虎,九强生物股票老虎国际,九强生物行情,九强生物股票行情,九强生物股价,九强生物股市,九强生物股票价格,九强生物股票交易,九强生物股票购买,九强生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}